Most Read Articles
05 Aug 2017
Discontinuation of antihypertensive drugs appears to have a detrimental effect, with a recent study reporting that the risk of acute myocardial infarction (AMI) substantially increases after more than 90 days of discontinuation.
Roshini Claire Anthony, 15 hours ago

Once-weekly doses of the glucagon-like peptide-1 receptor agonist exenatide plus insulin glargine improved glucose control and weight loss in patients whose type 2 diabetes (T2D) was uncontrolled on basal insulin and metformin, according to findings from the DURATION-7* trial.

03 Aug 2017
Cetuximab and docetaxel is safe and effective during postoperative radiotherapy for high-risk head and neck cancer patients who cannot receive cisplatin, a new study has found.
08 Sep 2017
Prediagnostic statin exposure appears to be associated with a significant reduction in breast cancer-specific mortality, with the survival benefit being more pronounced in women with oestrogen receptor (ER)-positive tumours, according to a study.

TNF inhibitors may slightly increase risk of developing severe extra-articular RA

10 Jul 2017

Patients treated with tumour necrosis factor (TNF) inhibitors are marginally prone to develop severe extra-articular rheumatoid arthritis (ExRA), a study suggests. In addition, rheumatoid factor (RF)-positive patients with disabling disease of long duration are at an increased risk of developing severe ExRA.

Researchers recruited a dynamic community-based cohort of patients with RA (n=1,977) to assess whether treatment with TNF inhibitors affected the risk of developing severe ExRA manifestations, as well as to study potential predictors for developing ExRA. They reviewed clinical records and identified cases of severe ExRA. Information on exposure to TNF inhibitors was obtained from a regional register.

Analysis of exposure to TNF inhibitors was done in a time-dependent fashion. Additionally, researchers compared the incidence of severe ExRA in exposed patients with the incidence in those who were unexposed. Cox regression models were used to evaluate possible predictors of severe ExRA.

A total of 17 patients had new onset of severe ExRA during treatment with TNF inhibitors in 2,400 person-years at risk (0.71/100; 95 percent CI, 0.41 to 1.13) compared with 104 in 15,599 person-years (0.67/100; 0.54 to 0.81) in those without TNF inhibitors, corresponding to an incidence rate ratio of 1.06 (0.60 to 1.78).

Anti-TNF‒treated patients had a hazard ratio for ExRA of 1.21 (1.02 to 1.43), adjusted for age and sex; the findings were similar in models adjusted for time-dependent Health Assessment Questionnaire and propensity for anti-TNF treatment.

The predictors for ExRA were male sex, positive RF, long disease duration and greater disability, according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
05 Aug 2017
Discontinuation of antihypertensive drugs appears to have a detrimental effect, with a recent study reporting that the risk of acute myocardial infarction (AMI) substantially increases after more than 90 days of discontinuation.
Roshini Claire Anthony, 15 hours ago

Once-weekly doses of the glucagon-like peptide-1 receptor agonist exenatide plus insulin glargine improved glucose control and weight loss in patients whose type 2 diabetes (T2D) was uncontrolled on basal insulin and metformin, according to findings from the DURATION-7* trial.

03 Aug 2017
Cetuximab and docetaxel is safe and effective during postoperative radiotherapy for high-risk head and neck cancer patients who cannot receive cisplatin, a new study has found.
08 Sep 2017
Prediagnostic statin exposure appears to be associated with a significant reduction in breast cancer-specific mortality, with the survival benefit being more pronounced in women with oestrogen receptor (ER)-positive tumours, according to a study.